These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 8065144

  • 1. Effect of cholecystokinin analogue caerulein and cholecystokinin antagonist lorglumide on pancreatic carcinogenesis in the rat.
    Sperti C, Militello C, Rovati L, Behboo R, Khajeturian E, Perasole A, Alaggio R, Pedrazzoli S.
    J Surg Oncol; 1994 Sep; 57(1):11-6. PubMed ID: 8065144
    [Abstract] [Full Text] [Related]

  • 2. Pancreatic secretory and trophic response to caerulein in rats: effect of proglumide and lorglumide.
    Varga G, Papp M, Scarpignato C.
    Fundam Clin Pharmacol; 1989 Sep; 3(3):295-306. PubMed ID: 2475419
    [Abstract] [Full Text] [Related]

  • 3. Effect of lorglumide (CR-1409) on pancreatic secretory and trophic response to caerulein in newborn rats.
    Papp M, Varga G, Folly G.
    Acta Physiol Hung; 1991 Sep; 78(1):61-7. PubMed ID: 1722380
    [Abstract] [Full Text] [Related]

  • 4. Effect of a new potent CCK antagonist, lorglumide, on caerulein- and bombesin-induced pancreatic secretion and growth in the rat.
    Scarpignato C, Varga G, Dobronyi I, Papp M.
    Br J Pharmacol; 1989 Mar; 96(3):661-9. PubMed ID: 2470456
    [Abstract] [Full Text] [Related]

  • 5. Effect of a new cholecystokinin receptor antagonist CR 1392 on caerulein-induced acute pancreatitis in rats.
    Otsuki M, Tani S, Okabayshi Y, Nakamura T, Fujii M, Fujisawa T, Baba S, Itoh H.
    Pancreas; 1989 Mar; 4(2):237-43. PubMed ID: 2474165
    [Abstract] [Full Text] [Related]

  • 6. Effect of the cholecystokinin-receptor antagonist lorglumide on pancreatic enzyme secretion stimulated by bombesin, food, and caerulein, giving similar plasma cholecystokinin concentrations in the dog.
    de Jong AJ, Singer MV, Jansen JB, Niebel W, Rovati LC, Lamers CB.
    Gut; 1991 Feb; 32(2):215-9. PubMed ID: 1864545
    [Abstract] [Full Text] [Related]

  • 7. Inhibitory effect of a cholecystokinin antagonist on pancreatic carcinogenesis after pancreatobiliary diversion.
    Watanapa P, Flaks B, Oztas H, Deprez PH, Calam J, Williamson RC.
    Br J Cancer; 1993 Apr; 67(4):663-7. PubMed ID: 8471422
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparative effects of CCK receptor antagonists on rat pancreatic secretion in vivo.
    Niederau M, Niederau C, Strohmeyer G, Grendell JH.
    Am J Physiol; 1989 Jan; 256(1 Pt 1):G150-7. PubMed ID: 2463767
    [Abstract] [Full Text] [Related]

  • 12. Role of cholecystokinin in the development of BOP-induced pancreatic lesions in hamsters.
    Meijers M, van Garderen-Hoetmer A, Lamers CB, Rovati LC, Jansen JB, Woutersen RA.
    Carcinogenesis; 1990 Dec; 11(12):2223-6. PubMed ID: 2265473
    [Abstract] [Full Text] [Related]

  • 13. Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas.
    Douglas BR, Woutersen RA, Jansen JB, de Jong AJ, Rovati LC, Lamers CB.
    Cancer Res; 1989 May 01; 49(9):2438-41. PubMed ID: 2706631
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Role of cholecystokinin in dietary fat-promoted azaserine-induced pancreatic carcinogenesis in rats.
    Appel MJ, Meijers M, Van Garderen-Hoetmer A, Lamers CB, Rovati LC, Sprij-Mooij D, Jansen JB, Woutersen RA.
    Br J Cancer; 1992 Jul 01; 66(1):46-50. PubMed ID: 1637675
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.